Palazzuoli A - Search Results

1

The predictive value of plasma biomarkers in discharged heart failure patients: the role of plasma BNP.

Beltrami M, Palazzuoli A, Ruocco G, Aspromonte N. Beltrami M, et al. Among authors: palazzuoli a. Minerva Cardioangiol. 2016 Apr;64(2):147-56. Epub 2015 Oct 16. Minerva Cardioangiol. 2016. PMID: 26474369 Review.

2

Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function.

Palazzuoli A, Calabria P, Vecchiato L, Quatrini I, Carrera A, Bruni F, Puccetti L, Pastorelli M, Pasqui AL, Auteri A. Palazzuoli A, et al. Clin Exp Med. 2004 Sep;4(1):44-9. doi: 10.1007/s10238-004-0037-0. Clin Exp Med. 2004. PMID: 15598085

3

Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.

Palazzuoli A, Quatrini I, Vecchiato L, Scali C, De Paola V, Iovine F, Martini G, Nuti R. Palazzuoli A, et al. Minerva Cardioangiol. 2005 Aug;53(4):321-8. Minerva Cardioangiol. 2005. PMID: 16177676 Clinical Trial.

4

Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries.

Palazzuoli A, Gennari L, Calabria P, Quatrini I, Vecchiato L, De Paola V, Campagna MS, Palazzuoli V, Nuti R. Palazzuoli A, et al. Among authors: palazzuoli v. Am J Cardiol. 2005 Dec 15;96(12):1705-10. doi: 10.1016/j.amjcard.2005.07.094. Epub 2005 Nov 2. Am J Cardiol. 2005. PMID: 16360361

5

A case of acute heart failure associated with Guillain-Barré syndrome.

Palazzuoli A, Lenzi C, Iovine F, Carrera A, Nuti R. Palazzuoli A, et al. Neurol Sci. 2006 Feb;26(6):447-50. doi: 10.1007/s10072-006-0531-0. Neurol Sci. 2006. PMID: 16601940

6

Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization.

Palazzuoli A, Poldermans D, Capobianco S, Giannotti G, Iovine F, Campagna MS, Calabrò A, Bagaglia S, Nuti R. Palazzuoli A, et al. Coron Artery Dis. 2006 Aug;17(5):419-23. doi: 10.1097/00019501-200608000-00004. Coron Artery Dis. 2006. PMID: 16845249

7

Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.

Palazzuoli A, Deckers J, Calabrò A, Campagna MS, Nuti R, Pastorelli M, Pasqui AL, Bruni F, Auteri A, Puccetti L. Palazzuoli A, et al. Am J Cardiol. 2006 Nov 15;98(10):1322-8. doi: 10.1016/j.amjcard.2006.06.023. Epub 2006 Sep 28. Am J Cardiol. 2006. PMID: 17134622

8

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R. Palazzuoli A, et al. Am Heart J. 2006 Dec;152(6):1096.e9-15. doi: 10.1016/j.ahj.2006.08.005. Am Heart J. 2006. PMID: 17161060 Clinical Trial.

9

Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.

Palazzuoli A, Iovine F, Gallotta M, Nuti R. Palazzuoli A, et al. Minerva Cardioangiol. 2007 Aug;55(4):491-6. Minerva Cardioangiol. 2007. PMID: 17653025 Review.

10

Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.

Palazzuoli A, Silverberg DS, Iovine F, Calabrò A, Campagna MS, Gallotta M, Nuti R. Palazzuoli A, et al. Am Heart J. 2007 Oct;154(4):645.e9-15. doi: 10.1016/j.ahj.2007.07.022. Am Heart J. 2007. PMID: 17892986 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters